{"infobox":{"dc_creator":"WooScraper_v1","dc_date_year":2007,"dc_identifier":"nl.oorg10123.2j.2007.643","dc_publisher":"oorg10123","dc_publisher_name":"Rijksinstituut voor Volksgezondheid en Milieu","dc_source":"https://www.rivm.nl/publicaties/use-of-health-economics-to-guide-drug-development-decisions-determining-optimal-values","dc_title":"The use of health economics to guide drug development decisions: Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approach | RIVM","dc_type":"2j","dc_type_description":"2j - Onderzoek","foi_extraMetadata":{},"foi_files":[],"foi_isWoo":"Ja","foi_page_title":"Onderzoek Rijksinstituut voor Volksgezondheid en Milieu","foi_publishedDate":"2007-10-04","foi_retrievedDate":"2024-12-01","tooiwl_type":"c_fdaee95e"},"resource":"nl.oorg10123.2j.2007.643"}